Results 91 to 100 of about 552 (107)

The Discovery of Manogepix/Fosmanogepix and Other Gwt1 Inhibitors for the Treatment of Invasive Fungal Infections

Medicinal Chemistry Reviews, 2019
Karen Joy Shaw
exaly   +2 more sources

Fungal Cytological Profiling of Candida albicans Exposed to Diverse Antifungal Agents Including the Novel Gwt1 inhibitor APX001A

Open Forum Infectious Diseases, 2017
Karen Joy Shaw
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

In Vitro Activity of APX2041, a New Gwt1 Inhibitor, and In Vivo Efficacy of the Prodrug APX2104 against Aspergillus fumigatus

Antimicrobial Agents and Chemotherapy, 2021
Juvvadi Pr, William Steinbach, Elliot Shwab   +2 more
exaly  

Fosmanogepix. GPI-anchored wall transfer protein 1 (Gwt1) (fungal) inhibitor, Treatment of invasive fungal infections

Drugs of the Future, 2021
R Thakare
exaly  

Evaluation of Resistance Development to the Gwt1 Inhibitor Manogepix (APX001A) in Candida Species

Antimicrobial Agents and Chemotherapy, 2019
Karen Joy Shaw, Mili Kapoor
exaly  

Synthesis of analogs of the Gwt1 inhibitor manogepix (APX001A) and in vitro evaluation against Cryptococcus spp

Bioorganic and Medicinal Chemistry Letters, 2019
Karen Joy Shaw, Mili Kapoor
exaly  

In Vitro and In Vivo Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against Cryptococcus

Antimicrobial Agents and Chemotherapy, 2018
John Perfect, Karen Joy Shaw, Mili Kapoor   +2 more
exaly